Rockefeller Capital Management L.P. - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 144 filers reported holding IMMUNITYBIO INC in Q4 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q4 2022$7
-99.9%
1,5400.0%0.00%
Q3 2022$7,000
+40.0%
1,5400.0%0.00%
Q2 2022$5,000
-37.5%
1,5400.0%0.00%
Q1 2022$8,000
-11.1%
1,5400.0%0.00%
Q4 2021$9,000
-90.7%
1,540
-84.6%
0.00%
-100.0%
Q3 2021$97,000
-32.6%
10,000
-1.0%
0.00%0.0%
Q2 2021$144,000
+7100.0%
10,100
+10000.0%
0.00%
Q1 2021$2,0001000.00%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2022
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$3,857,0000.50%
ORACLE INVESTMENT MANAGEMENT INC 400,013$2,244,0000.44%
HARBOURVEST PARTNERS LLC 335,709$1,883,0000.38%
Winning Points Advisors, LLC 60,126$339,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$541,0000.19%
SHEETS SMITH WEALTH MANAGEMENT 203,876$1,144,0000.16%
Delphia (USA) Inc. 25,504$143,0000.11%
Clearwater Capital Advisors, LLC 147,891$830,0000.10%
Corton Capital Inc. 36,843$207,0000.09%
Virtus ETF Advisers LLC 27,343$153,0000.07%
View complete list of IMMUNITYBIO INC shareholders